Next-Generation Hemostatic Compositions and Systems

This inventive concept envisions a paradigm shift in hemostatic compositions and systems, integrating advanced materials, personalized medicine, and wearable technologies to revolutionize bleeding control and management.

The original patent disclosed hemostatic compositions comprising an anion exchanger and a calcium salt. However, these compositions have limitations in terms of efficacy, specificity, and user convenience. The new inventive concept addresses these limitations by introducing nanofibrous matrices, personalized formulations, wearable devices, and targeted delivery mechanisms.

The next-generation hemostatic compositions and systems comprise nanofibrous matrices incorporating an anion exchanger and a calcium salt, which can self-assemble into hierarchical structures. Additionally, the concept includes personalized formulations tailored to individual bleeding profiles, wearable devices with sensors for detecting bleeding, and targeted delivery mechanisms using conjugated targeting moieties. These advancements enable enhanced hemostatic efficacy, improved user experience, and expanded applications in various medical fields.

The new claims introduce a significant inventive step by integrating advanced materials, personalized medicine, and wearable technologies, which are not obvious from the original patent. The use of nanofibrous matrices, conjugated targeting moieties, and wearable devices with sensors for detecting bleeding are novel and non-obvious features that distinguish the new inventive concept from the original patent.

Alternative embodiments of the inventive concept could include the use of different types of nanofibrous matrices, various targeting moieties, or alternative wearable device designs. Additionally, the concept could be adapted for use in veterinary medicine or in combination with other therapeutic agents.

The next-generation hemostatic compositions and systems have significant commercial potential in the medical device and pharmaceutical industries, with potential applications in trauma care, surgical settings, and emergency response situations. The market for these innovative products is expected to be substantial, driven by the growing need for effective bleeding control and management solutions.